VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q59220937 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233031.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q59220937‏
024 ‎‡a 0000-0002-4584-7366‏ ‎‡2 orcid‏
024 ‎‡a 7007016134‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q59220937‏
100 0 ‎‡a Francisco Fuentes Jiménez‏ ‎‡c researcher ORCID ID = 0000-0002-4584-7366‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Francisco Fuentes Jiménez‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I‏
670 ‎‡a Author's A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet.‏
670 ‎‡a Author's A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.‏
670 ‎‡a Author's ABCA1 gene variants regulate postprandial lipid metabolism in healthy men.‏
670 ‎‡a Author's [Addisonian crisis as initial manifestation of bilateral metastatic adrenal tumor]‏
670 ‎‡a Author's Apolipoprotein E gene promoter -219G->T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat‏
670 ‎‡a Author's Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.‏
670 ‎‡a Author's Autosomal recessive hypercholesterolemia in Spain.‏
670 ‎‡a Author's Autosomal recessive hypercholesterolemia in Spanish kindred due to a large deletion in the ARH gene‏
670 ‎‡a Author's Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia‏
670 ‎‡a Author's Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men‏
670 ‎‡a Author's Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors‏
670 ‎‡a Author's Chronic dietary fat intake modifies the postprandial response of hemostatic markers to a single fatty test meal.‏
670 ‎‡a Author's Circulating levels of endothelial function are modulated by dietary monounsaturated fat‏
670 ‎‡a Author's Clinical significance of increased serum ferritin levels‏
670 ‎‡a Author's Comparison of an oleic acid enriched-diet vs NCEP-I diet on LDL susceptibility to oxidative modifications‏
670 ‎‡a Author's Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study‏
670 ‎‡a Author's CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fa‏
670 ‎‡a Author's Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).‏
670 ‎‡a Author's Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia‏
670 ‎‡a Author's [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain]‏
670 ‎‡a Author's Diabetes, statins and FH‏
670 ‎‡a Author's Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso‏
670 ‎‡a Author's Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study.‏
670 ‎‡a Author's Dietary fat, genes and insulin sensitivity.‏
670 ‎‡a Author's Dietary fat modifies lipid metabolism in the adipose tissue of metabolic syndrome patients.‏
670 ‎‡a Author's Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.‏
670 ‎‡a Author's Effects of functional olive oil enriched with its own phenolic compounds on endothelial function in hypertensive patients. A randomised controlled trial.‏
670 ‎‡a Author's Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism‏
670 ‎‡a Author's Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.‏
670 ‎‡a Author's Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people.‏
670 ‎‡a Author's Factor VII polymorphisms influence the plasma response to diets with different fat content, in a healthy Caucasian population‏
670 ‎‡a Author's Gene variations of nitric oxide synthase regulate the effects of a saturated fat rich meal on endothelial function.‏
670 ‎‡a Author's Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia‏
670 ‎‡a Author's Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation‏
670 ‎‡a Author's Glucocorticoids and immunoglobulins in an acute respiratory distress syndrome secondary to varicella pneumoniae‏
670 ‎‡a Author's Hashimoto's disease presenting as encephalitis in a young woman‏
670 ‎‡a Author's Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship‏
670 ‎‡a Author's Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study).‏
670 ‎‡a Author's Interleukin 1B variant -1473G/C‏
670 ‎‡a Author's Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism.‏
670 ‎‡a Author's Lipoprotein(a) Levels in Familial Hypercholesterolemia‏
670 ‎‡a Author's Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men‏
670 ‎‡a Author's Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.‏
670 ‎‡a Author's [Mediterranean diet improves low density lipoprotein susceptibility to oxidative modifications]‏
670 ‎‡a Author's Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects.‏
670 ‎‡a Author's Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis.‏
670 ‎‡a Author's Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome.‏
670 ‎‡a Author's Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.‏
670 ‎‡a Author's New non-invasive method for early detection of metabolic syndrome in the working population‏
670 ‎‡a Author's NOS3 Glu298Asp polymorphism interacts with virgin olive oil phenols to determine the postprandial endothelial function in patients with the metabolic syndrome.‏
670 ‎‡a Author's Olive oil and the haemostatic system.‏
670 ‎‡a Author's Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.‏
670 ‎‡a Author's PCSK9 and lipoprotein‏
670 ‎‡a Author's PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.‏
670 ‎‡a Author's Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients.‏
670 ‎‡a Author's Polymorphism at the TRIB1 gene modulates plasma lipid levels: Insight from the Spanish familial hypercholesterolemia cohort study‏
670 ‎‡a Author's Postprandial antioxidant effect of the Mediterranean diet supplemented with coenzyme Q10 in elderly men and women‏
670 ‎‡a Author's Postprandial effects of the Mediterranean diet on oxidant and antioxidant status in elderly men and women‏
670 ‎‡a Author's Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).‏
670 ‎‡a Author's Predictive factors of achieving therapeutic goals of hypertriglyceridemia‏
670 ‎‡a Author's R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.‏
670 ‎‡a Author's Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study‏
670 ‎‡a Author's The -514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young population.‏
670 ‎‡a Author's The APOB -516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content‏
670 ‎‡a Author's The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.‏
670 ‎‡a Author's [The Mediterranean diet improves the profile of male smokers compared with the diet recommended by the American Cholesterol Program‏
670 ‎‡a Author's [The Mediterranean diet improves the profile of male smokers compared with the diet recommended by the American Cholesterol Program (NCEP-I)]‏
670 ‎‡a Author's Validation of a food frequency questionnaire in Spanish patients with familial hypercholesterolaemia.‏
670 ‎‡a Author's Validation of a non-invasive method for the early detection of metabolic syndrome: a diagnostic accuracy test in a working population‏
670 ‎‡a Author's White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial‏
909 ‎‡a (scopus) 7007016134‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000245847366‏ ‎‡9 1‏
919 ‎‡a whitefishreducescardiovascularriskfactorsinpatientswithmetabolicsyndromethewishcarestudyamulticenterrandomizedclinicaltrial‏ ‎‡A White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial‏ ‎‡9 1‏
919 ‎‡a autosomalrecessivehypercholesterolemiainspain‏ ‎‡A Autosomal recessive hypercholesterolemia in Spain.‏ ‎‡9 1‏
919 ‎‡a autosomalrecessivehypercholesterolemiainspanishkindredduetoalargedeletioninthearhgene‏ ‎‡A Autosomal recessive hypercholesterolemia in Spanish kindred due to a large deletion in the ARH gene‏ ‎‡9 1‏
919 ‎‡a basalplasmaconcentrationsofplantsterolscanpredictldl100responsetositosterolinpatientswithfamilialhypercholesterolemia‏ ‎‡A Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia‏ ‎‡9 1‏
919 ‎‡a butterandwalnutsbutnotoliveoilelicitpostprandialactivationofnucleartranscriptionfactorkappabinperipheralbloodmononuclearcellsfromhealthymen‏ ‎‡A Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men‏ ‎‡9 1‏
919 ‎‡a cardiovasculardiseaseinfamilialhypercholesterolaemiainfluenceoflowdensitylipoproteinreceptormutationtypeandclassicriskfactors‏ ‎‡A Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors‏ ‎‡9 1‏
919 ‎‡a chronicdietaryfatintakemodifiesthepostprandialresponseofhemostaticmarkerstoasinglefattytestmeal‏ ‎‡A Chronic dietary fat intake modifies the postprandial response of hemostatic markers to a single fatty test meal.‏ ‎‡9 1‏
919 ‎‡a circulatinglevelsofendothelialfunctionaremodulatedbydietarymonounsaturatedfat‏ ‎‡A Circulating levels of endothelial function are modulated by dietary monounsaturated fat‏ ‎‡9 1‏
919 ‎‡a clinicalsignificanceofincreasedserumferritinlevels‏ ‎‡A Clinical significance of increased serum ferritin levels‏ ‎‡9 1‏
919 ‎‡a comparisonofanoleicacidenricheddietvsncep1dietonldlsusceptibilitytooxidativemodifications‏ ‎‡A Comparison of an oleic acid enriched-diet vs NCEP-I diet on LDL susceptibility to oxidative modifications‏ ‎‡9 1‏
919 ‎‡a coronarycomputedtomographicangiographyfindingsandtheirtherapeuticimplicationsinasymptomaticpatientswithfamilialhypercholesterolemialessonsfromthesafeheartstudy‏ ‎‡A Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study‏ ‎‡9 1‏
919 ‎‡a coronarydietinterventionwitholiveoilandcardiovascularpreventionstudythecordioprevstudyrationalemethodsandbaselinecharacteristicsaclinicaltrialcomparingtheefficacyofamediterraneandietrichinoliveoilversusalowfa‏ ‎‡A CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fa‏ ‎‡9 1‏
919 ‎‡a coronaryheartdiseaseperipheralarterialdiseaseandstrokeinfamilialhypercholesterolaemiainsightsfromthesafeheartregistryspanishfamilialhypercholesterolaemiacohortstudy‏ ‎‡A Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).‏ ‎‡9 1‏
919 ‎‡a costeffectivenessofacascadescreeningprogramfortheearlydetectionoffamilialhypercholesterolemia‏ ‎‡A Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia‏ ‎‡9 1‏
919 ‎‡a costeffectivenessofrosuvastatinversussimvastatinatorvastatinandpitavastatininpatientswithhighandveryhighcardiovascularriskinspain‏ ‎‡A [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain]‏ ‎‡9 1‏
919 ‎‡a diabetesstatinsandfh‏ ‎‡A Diabetes, statins and FH‏ ‎‡9 1‏
919 ‎‡a diagnosticoytratamientodelahipercolesterolemiafamiliarenespanadocumentodeconsenso‏ ‎‡A Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso‏ ‎‡9 1‏
919 ‎‡a dietaryfatdifferentiallyinfluencesregulatoryendothelialfunctionduringthepostprandialstateinpatientswithmetabolicsyndromefromthelipgenestudy‏ ‎‡A Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study.‏ ‎‡9 1‏
919 ‎‡a pcsk9andlipoproteinalevelsare2predictorsofcoronaryarterycalcificationinasymptomaticpatientswithfamilialhypercholesterolemia‏ ‎‡A PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.‏ ‎‡9 1‏
919 ‎‡a dietaryfatmodifieslipidmetabolismintheadiposetissueofmetabolicsyndromepatients‏ ‎‡A Dietary fat modifies lipid metabolism in the adipose tissue of metabolic syndrome patients.‏ ‎‡9 1‏
919 ‎‡a earlydiagnosisandtreatmentoffamilialhypercholesterolemiaimprovingpatientoutcomes‏ ‎‡A Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.‏ ‎‡9 1‏
919 ‎‡a effectsoffunctionaloliveoilenrichedwithitsownphenoliccompoundsonendothelialfunctioninhypertensivepatientsarandomisedcontrolledtrial‏ ‎‡A Effects of functional olive oil enriched with its own phenolic compounds on endothelial function in hypertensive patients. A randomised controlled trial.‏ ‎‡9 1‏
919 ‎‡a effectsofthehumanapolipoproteina1promotergamutationonpostprandiallipoproteinmetabolism‏ ‎‡A Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism‏ ‎‡9 1‏
919 ‎‡a effectsofvariationsintheapoa1c3a4a5geneclusterondifferentparametersofpostprandiallipidmetabolisminhealthyyoungmen‏ ‎‡A Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.‏ ‎‡9 1‏
919 ‎‡a expressionofproinflammatoryproatherogenicgenesisreducedbythemediterraneandietinelderlypeople‏ ‎‡A Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people.‏ ‎‡9 1‏
919 ‎‡a factor7polymorphismsinfluencetheplasmaresponsetodietswithdifferentfatcontentinahealthycaucasianpopulation‏ ‎‡A Factor VII polymorphisms influence the plasma response to diets with different fat content, in a healthy Caucasian population‏ ‎‡9 1‏
919 ‎‡a genevariationsofnitricoxidesynthaseregulatetheeffectsofasaturatedfatrichmealonendothelialfunction‏ ‎‡A Gene variations of nitric oxide synthase regulate the effects of a saturated fat rich meal on endothelial function.‏ ‎‡9 1‏
919 ‎‡a geneticvariationsatabcg5g8genesmodulateplasmalipidsconcentrationsinpatientswithfamilialhypercholesterolemia‏ ‎‡A Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia‏ ‎‡9 1‏
919 ‎‡a geneticvariationsoftheapolipoproteinegenedeterminetheplasmatriglyceridelevelsafterhearttransplantation‏ ‎‡A Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation‏ ‎‡9 1‏
919 ‎‡a glucocorticoidsandimmunoglobulinsinanacuterespiratorydistresssyndromesecondarytovaricellapneumoniae‏ ‎‡A Glucocorticoids and immunoglobulins in an acute respiratory distress syndrome secondary to varicella pneumoniae‏ ‎‡9 1‏
919 ‎‡a hashimotosdiseasepresentingasencephalitisinayoungwoman‏ ‎‡A Hashimoto's disease presenting as encephalitis in a young woman‏ ‎‡9 1‏
919 ‎‡a homozygousfamilialhypercholesterolemiainspainprevalenceandphenotypegenotyperelationship‏ ‎‡A Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship‏ ‎‡9 1‏
919 ‎‡a influenceofobesityandmetabolicdiseaseoncarotidatherosclerosisinpatientswithcoronaryarterydiseasecordioprevstudy‏ ‎‡A Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study).‏ ‎‡9 1‏
919 ‎‡a interleukin1bvariant1473g100‏ ‎‡A Interleukin 1B variant -1473G/C‏ ‎‡9 1‏
919 ‎‡a interleukin1bvariant1473g100rs1143623influencestriglycerideandinterleukin6metabolism‏ ‎‡A Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism.‏ ‎‡9 1‏
919 ‎‡a lipoproteinalevelsinfamilialhypercholesterolemia‏ ‎‡A Lipoprotein(a) Levels in Familial Hypercholesterolemia‏ ‎‡9 1‏
919 ‎‡a lowfatandhighmonounsaturatedfattyaciddietsdecreaseplasmacholesterolestertransferproteinconcentrationsinyounghealthynormolipemicmen‏ ‎‡A Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men‏ ‎‡9 1‏
919 ‎‡a mediterraneanandlowfatdietsimproveendothelialfunctioninhypercholesterolemicmen‏ ‎‡A Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.‏ ‎‡9 1‏
919 ‎‡a polymorphismexon1variantatthelocusofthescavengerreceptorclassbtype1‏ ‎‡A A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I‏ ‎‡9 1‏
919 ‎‡a mediterraneandietimproveslowdensitylipoproteinsusceptibilitytooxidativemodifications‏ ‎‡A [Mediterranean diet improves low density lipoprotein susceptibility to oxidative modifications]‏ ‎‡9 1‏
919 ‎‡a mediterraneandietsupplementedwithcoenzymeq10inducespostprandialchangesinp53inresponsetooxidativednadamageinelderlysubjects‏ ‎‡A Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects.‏ ‎‡9 1‏
919 ‎‡a metabolicphenotypesofobesityinfluencetriglycerideandinflammationhomoeostasis‏ ‎‡A Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis.‏ ‎‡9 1‏
919 ‎‡a polymorphismexon1variantatthelocusofthescavengerreceptorclassbtype1scarb1geneisassociatedwithdifferencesininsulinsensitivityinhealthypeopleduringtheconsumptionofanoliveoilrichdiet‏ ‎‡A A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet.‏ ‎‡9 1‏
919 ‎‡a abca1genevariantsregulatepostprandiallipidmetabolisminhealthymen‏ ‎‡A ABCA1 gene variants regulate postprandial lipid metabolism in healthy men.‏ ‎‡9 1‏
919 ‎‡a singlenucleotidepolymorphismoftheapolipoproteina5gene1131t100modulatespostprandiallipoproteinmetabolism‏ ‎‡A A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.‏ ‎‡9 1‏
919 ‎‡a moderatetohighintensitytrainingandahypocaloricmediterraneandietenhanceendothelialprogenitorcellsandfitnessinsubjectswiththemetabolicsyndrome‏ ‎‡A Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome.‏ ‎‡9 1‏
919 ‎‡a phenoliccontentofvirginoliveoilimprovesischemicreactivehyperemiainhypercholesterolemicpatients‏ ‎‡A Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients.‏ ‎‡9 1‏
919 ‎‡a polymorphismatthetrib1genemodulatesplasmalipidlevelsinsightfromthespanishfamilialhypercholesterolemiacohortstudy‏ ‎‡A Polymorphism at the TRIB1 gene modulates plasma lipid levels: Insight from the Spanish familial hypercholesterolemia cohort study‏ ‎‡9 1‏
919 ‎‡a validationofanoninvasivemethodfortheearlydetectionofmetabolicsyndromeadiagnosticaccuracytestinaworkingpopulation‏ ‎‡A Validation of a non-invasive method for the early detection of metabolic syndrome: a diagnostic accuracy test in a working population‏ ‎‡9 1‏
919 ‎‡a statinsdonotincreasetheriskofdevelopingtype2diabetesinfamilialhypercholesterolemiathesafeheartstudy‏ ‎‡A Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study‏ ‎‡9 1‏
919 ‎‡a postprandialantioxidanteffectofthemediterraneandietsupplementedwithcoenzymeq10inelderlymenandwomen‏ ‎‡A Postprandial antioxidant effect of the Mediterranean diet supplemented with coenzyme Q10 in elderly men and women‏ ‎‡9 1‏
919 ‎‡a oliveoilandthehaemostaticsystem‏ ‎‡A Olive oil and the haemostatic system.‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationoffamilialhypercholesterolemiainspainidentificationof39noveland77recurrentmutationsinldlr‏ ‎‡A Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.‏ ‎‡9 1‏
919 ‎‡a validationofafoodfrequencyquestionnaireinspanishpatientswithfamilialhypercholesterolaemia‏ ‎‡A Validation of a food frequency questionnaire in Spanish patients with familial hypercholesterolaemia.‏ ‎‡9 1‏
919 ‎‡a postprandialeffectsofthemediterraneandietonoxidantandantioxidantstatusinelderlymenandwomen‏ ‎‡A Postprandial effects of the Mediterranean diet on oxidant and antioxidant status in elderly men and women‏ ‎‡9 1‏
919 ‎‡a mediterraneandietimprovestheprofileofmalesmokerscomparedwiththedietrecommendedbytheamericancholesterolprogramncep1‏ ‎‡A [The Mediterranean diet improves the profile of male smokers compared with the diet recommended by the American Cholesterol Program (NCEP-I)]‏ ‎‡9 1‏
919 ‎‡a newnoninvasivemethodforearlydetectionofmetabolicsyndromeintheworkingpopulation‏ ‎‡A New non-invasive method for early detection of metabolic syndrome in the working population‏ ‎‡9 1‏
919 ‎‡a oxidativestressisassociatedwiththenumberofcomponentsofmetabolicsyndromelipgenestudy‏ ‎‡A Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.‏ ‎‡9 1‏
919 ‎‡a mediterraneandietimprovestheprofileofmalesmokerscomparedwiththedietrecommendedbytheamericancholesterolprogram‏ ‎‡A [The Mediterranean diet improves the profile of male smokers compared with the diet recommended by the American Cholesterol Program‏ ‎‡9 1‏
919 ‎‡a nos3glu298asppolymorphisminteractswithvirginoliveoilphenolstodeterminethepostprandialendothelialfunctioninpatientswiththemetabolicsyndrome‏ ‎‡A NOS3 Glu298Asp polymorphism interacts with virgin olive oil phenols to determine the postprandial endothelial function in patients with the metabolic syndrome.‏ ‎‡9 1‏
919 ‎‡a r353qpolymorphisminthefactor7geneandcardiovascularriskinheterozygousfamilialhypercholesterolemiaacasecontrolstudy‏ ‎‡A R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.‏ ‎‡9 1‏
919 ‎‡a effectofapoegenotypeandsexonapoeplasmaconcentrationisdeterminedbydietaryfatinhealthysubjects‏ ‎‡A The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.‏ ‎‡9 1‏
919 ‎‡a dietaryfatgenesandinsulinsensitivity‏ ‎‡A Dietary fat, genes and insulin sensitivity.‏ ‎‡9 1‏
919 ‎‡a 514100tpolymorphisminthehepaticlipasegenepromoterisassociatedwithinsulinsensitivityinahealthyyoungpopulation‏ ‎‡A The -514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young population.‏ ‎‡9 1‏
919 ‎‡a predictivefactorsofachievingtherapeuticgoalsofhypertriglyceridemia‏ ‎‡A Predictive factors of achieving therapeutic goals of hypertriglyceridemia‏ ‎‡9 1‏
919 ‎‡a apob516ctpolymorphismisassociatedwithdifferencesininsulinsensitivityinhealthymalesduringtheconsumptionofdietswithdifferentfatcontent‏ ‎‡A The APOB -516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content‏ ‎‡9 1‏
919 ‎‡a pcsk9andlipoprotein‏ ‎‡A PCSK9 and lipoprotein‏ ‎‡9 1‏
919 ‎‡a predictingcardiovasculareventsinfamilialhypercholesterolemiathesafeheartregistryspanishfamilialhypercholesterolemiacohortstudy‏ ‎‡A Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).‏ ‎‡9 1‏
919 ‎‡a addisoniancrisisasinitialmanifestationofbilateralmetastaticadrenaltumor‏ ‎‡A [Addisonian crisis as initial manifestation of bilateral metastatic adrenal tumor]‏ ‎‡9 1‏
919 ‎‡a apolipoproteinegenepromoter219gtpolymorphismincreasesldlcholesterolconcentrationsandsusceptibilitytooxidationinresponsetoadietrichinsaturatedfat‏ ‎‡A Apolipoprotein E gene promoter -219G->T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat‏ ‎‡9 1‏
919 ‎‡a attainmentofldlcholesteroltreatmentgoalsinchildrenandadolescentswithfamilialhypercholesterolemiathesafeheartfollowupregistry‏ ‎‡A Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000116921363‏
996 ‎‡2 ISNI|0000000060997640‏
996 ‎‡2 LC|no2016010230‏
996 ‎‡2 BIBSYS|1698994100055‏
996 ‎‡2 SUDOC|112044964‏
996 ‎‡2 BNC|981058612950906706‏
996 ‎‡2 DNB|1108106889‏
996 ‎‡2 SUDOC|156826607‏
996 ‎‡2 BNE|XX5197801‏
996 ‎‡2 NKC|jo2014846699‏
996 ‎‡2 LC|n 99012865‏
996 ‎‡2 BNE|XX1184501‏
996 ‎‡2 NDL|00934510‏
996 ‎‡2 ISNI|0000000059797350‏
996 ‎‡2 ISNI|0000000459789501‏
996 ‎‡2 LC|n 99835305‏
996 ‎‡2 NYNYRILM|91239‏
996 ‎‡2 BNF|14466767‏
996 ‎‡2 BNE|XX5837000‏
996 ‎‡2 LC|no2022155450‏
996 ‎‡2 SUDOC|121007790‏
996 ‎‡2 BNE|XX1034104‏
996 ‎‡2 DNB|1057069833‏
996 ‎‡2 LC|no2005061516‏
996 ‎‡2 ISNI|0000000059383932‏
996 ‎‡2 LC|ns2024001965‏
996 ‎‡2 ISNI|000000006108793X‏
996 ‎‡2 LC|no2004081548‏
996 ‎‡2 BNE|XX5390884‏
996 ‎‡2 LC|n 2021000852‏
996 ‎‡2 ISNI|0000000501709844‏
996 ‎‡2 LC|no 92011162‏
996 ‎‡2 ISNI|0000000064872693‏
996 ‎‡2 BNE|XX1589235‏
996 ‎‡2 BNE|XX968651‏
996 ‎‡2 BNC|981058511811706706‏
996 ‎‡2 DNB|1073270106‏
996 ‎‡2 LC|n 50015990‏
996 ‎‡2 SUDOC|266229751‏
996 ‎‡2 BNE|XX5619170‏
996 ‎‡2 BNF|16731935‏
996 ‎‡2 ISNI|0000000061421977‏
996 ‎‡2 BNE|XX1561553‏
996 ‎‡2 DNB|1198352981‏
996 ‎‡2 LC|no2011190196‏
996 ‎‡2 ISNI|0000000060293192‏
996 ‎‡2 BNCHL|10000000000000000036892‏
996 ‎‡2 LC|no2009086609‏
996 ‎‡2 DNB|1047921448‏
996 ‎‡2 BNE|XX5408219‏
996 ‎‡2 BNF|16510089‏
996 ‎‡2 J9U|987007458292805171‏
996 ‎‡2 DNB|1057101575‏
996 ‎‡2 BNE|XX1325478‏
996 ‎‡2 LC|n 99018358‏
996 ‎‡2 BNE|XX1774837‏
996 ‎‡2 DNB|188399801‏
996 ‎‡2 ISNI|0000000061374242‏
996 ‎‡2 PTBNP|1650394‏
996 ‎‡2 KRNLK|KAC202277887‏
996 ‎‡2 DNB|1057509051‏
996 ‎‡2 LC|no2004095223‏
996 ‎‡2 BNE|XX4821252‏
996 ‎‡2 LC|no2008024890‏
996 ‎‡2 BNE|XX6333572‏
996 ‎‡2 BNE|XX862263‏
996 ‎‡2 DNB|132414309‏
996 ‎‡2 ISNI|0000000370501321‏
996 ‎‡2 BNE|XX4672074‏
996 ‎‡2 BNE|XX1628764‏
996 ‎‡2 BNE|XX969423‏
996 ‎‡2 BNE|XX5818372‏
996 ‎‡2 ISNI|0000000118291940‏
996 ‎‡2 BAV|495_29489‏
996 ‎‡2 LC|no2008152134‏
996 ‎‡2 BNE|XX985322‏
996 ‎‡2 BNE|XX1506952‏
996 ‎‡2 BNE|XX1673177‏
996 ‎‡2 DNB|118666312X‏
996 ‎‡2 BNE|XX1068072‏
996 ‎‡2 BNE|XX1088725‏
996 ‎‡2 SUDOC|112676774‏
996 ‎‡2 BNCHL|10000000000000000815656‏
996 ‎‡2 ISNI|0000000108204217‏
996 ‎‡2 ISNI|000000044468247X‏
996 ‎‡2 ISNI|0000000059351535‏
996 ‎‡2 BNE|XX1691726‏
996 ‎‡2 LC|no2009167040‏
996 ‎‡2 DNB|1056569077‏
996 ‎‡2 ISNI|0000000060723535‏
996 ‎‡2 BNE|XX1512632‏
996 ‎‡2 NTA|071758399‏
996 ‎‡2 BNE|XX1552754‏
996 ‎‡2 NTA|325848122‏
996 ‎‡2 BNE|XX1721590‏
996 ‎‡2 BNC|981058615957406706‏
996 ‎‡2 BNCHL|10000000000000000796416‏
996 ‎‡2 BNF|16508732‏
996 ‎‡2 SUDOC|178627100‏
996 ‎‡2 BNF|17958139‏
996 ‎‡2 BNC|981058612301806706‏
996 ‎‡2 KRNLK|KAC202164764‏
996 ‎‡2 SUDOC|17113883X‏
996 ‎‡2 ISNI|0000000118303884‏
996 ‎‡2 JPG|500252768‏
996 ‎‡2 BNE|XX1088543‏
996 ‎‡2 LC|no2021061106‏
996 ‎‡2 ISNI|0000000051171513‏
996 ‎‡2 LC|no2015045329‏
996 ‎‡2 NUKAT|n 2016199191‏
996 ‎‡2 PLWABN|9810561818505606‏
996 ‎‡2 LC|n 00038736‏
996 ‎‡2 LC|no 00079098‏
996 ‎‡2 J9U|987007329614105171‏
996 ‎‡2 BNE|XX5454898‏
996 ‎‡2 BNE|XX4892760‏
996 ‎‡2 LC|no2014165933‏
996 ‎‡2 BIBSYS|1533887372378‏
996 ‎‡2 BNE|XX998353‏
996 ‎‡2 DNB|143026550‏
996 ‎‡2 BNE|XX966152‏
996 ‎‡2 PTBNP|238273‏
996 ‎‡2 BNC|981058515997406706‏
996 ‎‡2 BNE|XX1538280‏
996 ‎‡2 BNE|XX1007319‏
996 ‎‡2 BNE|XX6188239‏
996 ‎‡2 NUKAT|n 2020143356‏
996 ‎‡2 LC|n 2010054468‏
996 ‎‡2 DNB|1057482714‏
996 ‎‡2 BNCHL|10000000000000000816817‏
996 ‎‡2 LC|n 2019056776‏
996 ‎‡2 SUDOC|184211158‏
996 ‎‡2 BNE|XX1161387‏
996 ‎‡2 ISNI|0000000071401400‏
996 ‎‡2 BNC|981058512058706706‏
996 ‎‡2 ISNI|0000000118376768‏
996 ‎‡2 BNF|14100021‏
996 ‎‡2 BNC|981058511882106706‏
996 ‎‡2 BNE|XX1088648‏
996 ‎‡2 ISNI|0000000065478962‏
996 ‎‡2 DNB|1132587379‏
996 ‎‡2 BNE|XX1239201‏
996 ‎‡2 BNE|XX1166610‏
996 ‎‡2 ISNI|0000000117632387‏
996 ‎‡2 LC|n 2023045355‏
996 ‎‡2 LC|n 2021182850‏
996 ‎‡2 ISNI|0000000059351578‏
996 ‎‡2 BLBNB|001449894‏
996 ‎‡2 BNE|XX1704577‏
996 ‎‡2 BNC|981061111871106706‏
996 ‎‡2 BNC|981058617431506706‏
996 ‎‡2 LC|n 2024021962‏
996 ‎‡2 NLA|000035146862‏
996 ‎‡2 SUDOC|156026686‏
996 ‎‡2 BNE|XX1538492‏
996 ‎‡2 LC|n 82032390‏
996 ‎‡2 BNE|XX897820‏
996 ‎‡2 ISNI|0000000060908580‏
996 ‎‡2 BNC|981058515200606706‏
996 ‎‡2 LC|n 2006048351‏
996 ‎‡2 BNE|XX5638501‏
996 ‎‡2 DNB|127055770X‏
996 ‎‡2 RERO|A024490082‏
996 ‎‡2 LC|nr 96025643‏
996 ‎‡2 ISNI|0000000077455645‏
996 ‎‡2 LC|no2024071502‏
996 ‎‡2 ISNI|0000000359577667‏
996 ‎‡2 BNE|XX970930‏
996 ‎‡2 BNE|XX1029309‏
996 ‎‡2 ISNI|0000000059343121‏
996 ‎‡2 DNB|1020905042‏
996 ‎‡2 BNE|XX1020425‏
996 ‎‡2 LC|n 2009003214‏
996 ‎‡2 DNB|1053297149‏
996 ‎‡2 BNE|XX6427529‏
996 ‎‡2 J9U|987007381383505171‏
996 ‎‡2 BNE|XX1583994‏
996 ‎‡2 BNE|XX1055562‏
996 ‎‡2 ISNI|0000000053880508‏
996 ‎‡2 SUDOC|243718683‏
996 ‎‡2 BNE|XX1688529‏
996 ‎‡2 DNB|128490373‏
996 ‎‡2 LC|n 2018061844‏
996 ‎‡2 BIBSYS|1592544500318‏
996 ‎‡2 NTA|159421608‏
996 ‎‡2 BNE|XX1538149‏
996 ‎‡2 SUDOC|228541158‏
996 ‎‡2 ISNI|0000000033729528‏
996 ‎‡2 BNE|XX828618‏
996 ‎‡2 ISNI|0000000059562455‏
996 ‎‡2 BNE|XX1325503‏
996 ‎‡2 BNE|XX1325263‏
996 ‎‡2 LC|n 2006183256‏
996 ‎‡2 SUDOC|240955544‏
996 ‎‡2 ISNI|0000000059278059‏
996 ‎‡2 LC|nb2011022251‏
996 ‎‡2 BNE|XX1535460‏
996 ‎‡2 ISNI|0000000117716775‏
996 ‎‡2 BNF|12433491‏
996 ‎‡2 RERO|A000094636‏
996 ‎‡2 SUDOC|171908600‏
996 ‎‡2 BNF|17088901‏
996 ‎‡2 LC|no2011121028‏
996 ‎‡2 BNE|XX4704760‏
996 ‎‡2 BNE|XX876281‏
996 ‎‡2 ISNI|0000000059529591‏
996 ‎‡2 BNE|XX1136705‏
996 ‎‡2 LC|no 99070810‏
996 ‎‡2 BNE|XX1556210‏
996 ‎‡2 BNE|XX4744493‏
996 ‎‡2 BNF|14495768‏
996 ‎‡2 LC|no2021038151‏
996 ‎‡2 DNB|1057195421‏
996 ‎‡2 JPG|500236598‏
996 ‎‡2 BNCHL|10000000000000000116777‏
996 ‎‡2 BNE|XX1425219‏
996 ‎‡2 BNCHL|10000000000000000116773‏
996 ‎‡2 BNCHL|10000000000000000126470‏
996 ‎‡2 BNE|XX1481834‏
996 ‎‡2 LC|no2011137189‏
996 ‎‡2 BNC|981058608331806706‏
996 ‎‡2 RERO|A011732041‏
996 ‎‡2 LC|ns2024002632‏
996 ‎‡2 SUDOC|183869834‏
996 ‎‡2 SUDOC|028329597‏
996 ‎‡2 ISNI|0000000036978925‏
996 ‎‡2 LIH|LNB:CC_b_Q;=BP‏
996 ‎‡2 LC|ns2012001747‏
996 ‎‡2 LC|no2019068550‏
996 ‎‡2 BNE|XX1728003‏
996 ‎‡2 LC|n 2017002277‏
996 ‎‡2 ISNI|0000000044737224‏
996 ‎‡2 NUKAT|nx2023665539‏
996 ‎‡2 BNE|XX1506768‏
996 ‎‡2 LC|no2005050258‏
996 ‎‡2 LC|n 98101611‏
996 ‎‡2 DNB|1193950953‏
996 ‎‡2 ISNI|0000000059824443‏
996 ‎‡2 NSK|000680267‏
996 ‎‡2 BNE|XX1137193‏
996 ‎‡2 LC|no 98107672‏
996 ‎‡2 ISNI|0000000459673867‏
996 ‎‡2 NUKAT|n 2010049346‏
996 ‎‡2 ISNI|0000000042751399‏
996 ‎‡2 SUDOC|072245182‏
996 ‎‡2 BNF|11885964‏
996 ‎‡2 ISNI|0000000391081557‏
996 ‎‡2 BNE|XX1454208‏
996 ‎‡2 LC|no2006070432‏
996 ‎‡2 LC|no2006045416‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏